Jammu, In a significant international academic achievement, Prof. (Dr.) D.N. Sharma, Executive Director & CEO, AIIMS Jammu, participated in the prestigious American Brachytherapy Society (ABS) Annual Conference 2026, held from 17–20 June 2026 in Los Angeles, California, USA. The conference brought together leading experts, researchers, clinicians and healthcare professionals from across the world to deliberate on the latest advancements in brachytherapy and radiation oncology.
Prof. (Dr.) D.N. Sharma was among the experts featured in the official conference programme, reflecting his distinguished contributions to the field of radiation oncology (Brachytherapy) and cancer care. His participation in this internationally acclaimed scientific forum provided an opportunity to engage with global leaders and contribute to discussions on emerging trends, innovative technologies and evidence-based practices in precision cancer treatment.
The American Brachytherapy Society Annual Conference is recognized as one of the foremost international platforms dedicated to brachytherapy and radiation oncology. It serves as a hub for scientific exchange, collaborative learning and dissemination of cutting-edge research aimed at improving cancer treatment outcomes worldwide.
A major highlight of the conference was the active academic participation of Prof. (Dr.) D.N. Sharma in the scientific programme. He delivered an invited lecture on “Operational Efficiency of a Multi-Site Practice (GYN, Prostate, Others)” during the session titled “Socioeconomic Session I: Adding Value through Efficient Resource Utilization” held on 18 June 2026. As part of a distinguished panel comprising eminent international faculty and experts from leading healthcare institutions, Prof. (Dr.) D.N. Sharma shared insights on optimizing oncology services, enhancing operational efficiency and improving resource utilization in cancer care. The session also witnessed engaging scientific discussions and exchange of perspectives among global experts on contemporary challenges, innovative solutions and best practices in radiation oncology and healthcare management.
Another highlight of the conference was the presentation of Prof. (Dr.) D.N. Sharma’s scientific work titled “Doppler Guided Interstitial Brachytherapy for Residual Neck Node Metastases” during the scientific programme of the conference. The research was showcased through a presentation, providing an opportunity to share the findings with distinguished international experts, researchers and faculty members attending the conference.
These academic engagements provided a valuable platform for knowledge exchange, scientific interaction and professional collaboration with eminent faculty and distinguished experts from different countries. The participation further facilitated discussions on innovative approaches and evolving practices aimed at advancing cancer care and improving patient outcomes.
Prof. (Dr.) D.N. Sharma’s participation in these scientific deliberations reflects the growing recognition of Indian expertise in radiation oncology and brachytherapy on international academic platforms. His contributions at the ABS Annual Conference 2026 highlight a continued commitment to academic excellence, innovation, research and global collaboration in advancing cancer care.
The participation of Prof. (Dr.) D.N. Sharma in the American Brachytherapy Society Annual Conference 2026 marks another important milestone in strengthening India’s presence on global academic platforms and advancing excellence in healthcare, medical education and research.
